Evidence for the path to cervical cancer elimination
Menée à une échelle internationale, cette étude présente une estimation de l'incidence du cancer de l'utérus et de la mortalité associée, pour l'année 2018
Eradication of cervical cancer is at the forefront of the global health agenda with the launch of the WHO Initiative for the Elimination of Cervical Cancer in 2018. Human papillomavirus (HPV) vaccination is expected to be a priority agenda item on health for the 2020 G20 Summit in Riyadh following the 2019 commitment to universal access to vaccination in the G20 Osaka Leaders' Declaration and the Okayama Declaration of the G20 Health Ministers. This political momentum should be coupled with the latest evidence to pinpoint outstanding areas for action and to implement responsive strategies. Cervical cancer is one of the top five cancers with the greatest proportion of avoidable cancer mortality—premature deaths resulting from health system failures that could otherwise be avoided on the basis of existing medical advancements and with access to high-quality health care. As evidenced by the importance of quality markers in health care, including the effectiveness and timeliness of care, an immense opportunity exists to bridge the gap in what can be achieved and what is achieved on the prevention and treatment of cervical cancer. Fundamental to any response is reliable assessment of the global burden of cervical cancer.(...)